| Dr Roberto A Molina, MD | |
|
75 Colonia De Salud, Suite 200c, Sierra Vista, AZ 85635-2487 | |
| (520) 335-2800 | |
| (520) 335-2964 |
| Full Name | Dr Roberto A Molina |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 16 Years |
| Location | 75 Colonia De Salud, Sierra Vista, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588803837 | NPI | - | NPPES |
| 779876 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 47030 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Canyon Vista Medical Center | Sierra vista, AZ | Hospital |
| Copper Queen Community Hospital | Bisbee, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sierra Vista Regional Health Center Medical Group Llc | 3779732854 | 35 |
News Archive
New method could sensitively detect pre-atherosclerotic regions that otherwise showed no clinical signs of atherosclerosis
The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert review of evolving evidence.
Oncolytics Biotech Inc. today announced that an abstract covering preclinical research with reovirus (REOLYSIN) is available on the European CanCer Organisation (ECCO). The research is scheduled to be presented at the 22nd EORTC-NCI-AACR symposium on Molecular Targets and Cancer Therapeutics being held in Berlin, Germany from November 16th - 19th 2010.
A study led by researchers at Universitat Jaume I de Castellón has identified one of the genetic causes underlying the higher rate of melanoma in men. The results have been published in Biology of Sex Differences.
› Verified 8 days ago
| Entity Name | Sierra Vista Regional Health Center Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043575483 PECOS PAC ID: 3779732854 Enrollment ID: O20121004000679 |
News Archive
New method could sensitively detect pre-atherosclerotic regions that otherwise showed no clinical signs of atherosclerosis
The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert review of evolving evidence.
Oncolytics Biotech Inc. today announced that an abstract covering preclinical research with reovirus (REOLYSIN) is available on the European CanCer Organisation (ECCO). The research is scheduled to be presented at the 22nd EORTC-NCI-AACR symposium on Molecular Targets and Cancer Therapeutics being held in Berlin, Germany from November 16th - 19th 2010.
A study led by researchers at Universitat Jaume I de Castellón has identified one of the genetic causes underlying the higher rate of melanoma in men. The results have been published in Biology of Sex Differences.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Roberto A Molina, MD 5750 E Highway 90 Ste 200, Sierra Vista, AZ 85635-9113 Ph: (520) 263-3979 | Dr Roberto A Molina, MD 75 Colonia De Salud, Suite 200c, Sierra Vista, AZ 85635-2487 Ph: (520) 335-2800 |
News Archive
New method could sensitively detect pre-atherosclerotic regions that otherwise showed no clinical signs of atherosclerosis
The National Comprehensive Cancer Network® (NCCN®) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert review of evolving evidence.
Oncolytics Biotech Inc. today announced that an abstract covering preclinical research with reovirus (REOLYSIN) is available on the European CanCer Organisation (ECCO). The research is scheduled to be presented at the 22nd EORTC-NCI-AACR symposium on Molecular Targets and Cancer Therapeutics being held in Berlin, Germany from November 16th - 19th 2010.
A study led by researchers at Universitat Jaume I de Castellón has identified one of the genetic causes underlying the higher rate of melanoma in men. The results have been published in Biology of Sex Differences.
› Verified 8 days ago
Jose Ignacio Gonzalez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 157 N Coronado Dr, Ste A, Sierra Vista, AZ 85635 Phone: 520-458-1208 Fax: 520-458-1675 | |
Rebecca Pradhan-nara, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 77 Calle Portal, Suite B260a, Sierra Vista, AZ 85635 Phone: 520-226-4338 Fax: 520-335-8705 | |
Mustafa Faisal Mustafa Douglas, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 5700 E Highway 90, Sierra Vista, AZ 85635 Phone: 520-263-3190 | |
Mohammad Ali Hasan Hudeeb, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5700 E Highway 90, Hospitalist Office, Sierra Vista, AZ 85635 Phone: 520-263-3180 Fax: 520-263-3184 | |
Dr. Andrew Navindra Latchman, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 198 S Coronado Dr Ste A, Sierra Vista, AZ 85635 Phone: 520-220-5020 | |
Philip Lesueur, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 E Wilcox Dr, Sierra Vista, AZ 85635 Phone: 520-459-3116 Fax: 520-459-7397 | |
Richard M Gladding, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2530 E Wilcox Dr, Sierra Vista, AZ 85635 Phone: 520-417-0586 Fax: 520-417-4207 |